Bipolar Disorder Trial, Recruiting NCT05698589 Sponsor: University Hospital, Strasbourg, France Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT05698589
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been informed of the results of their initial medical assessment
  • People who are covered by a social health insurance plan (either as the main member or as a family member of a main member)
  • People who have been diagnosed with one or more chronic psychiatric conditions — such as schizophrenia, schizoaffective disorder, bipolar disorder, recurrent major depression, or borderline personality disorder — or a neurodevelopmental condition such as autism spectrum disorder, and who receive care as an outpatient or in a day hospital
  • People whose condition is rated as not severely acute by their psychiatrist, using a standard clinical scale (CGI-Severity score below 6)
  • People whose responses to a self-stigma questionnaire show a moderate to high level of self-stigma (ISMI score above 2.5)

Who may not be able to join:

  • People who are currently in an exclusion period due to a previous or ongoing research study
  • People who are already taking part in an interventional study that involves psychotherapy or an experimental medication
  • People who are currently experiencing an acute episode of their condition, as assessed by their psychiatrist using a standard clinical scale
  • People who are in a medical emergency or a life-threatening situation
  • People who have an intellectual disability, defined as an IQ below 70, as estimated through a specific cognitive assessment tool
  • People who are receiving psychiatric care under legal constraint, or whose freedom is restricted due to a court order
  • People who do not have a sufficient ability to speak and read French

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0033388116312

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 April 2023
Est. completion
1 March 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Internalized Stigma of Mental Illness inventory (ISMI); Internalized Stigma of Mental Illness inventory (ISMI); Internalized Stigma of Mental Illness inventory (ISMI); Internalized Stigma of Mental Illness inventory (ISMI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov